<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03944408</url>
  </required_header>
  <id_info>
    <org_study_id>wzchencs</org_study_id>
    <nct_id>NCT03944408</nct_id>
  </id_info>
  <brief_title>A Metal Bare Stent With 125 Iodine （125I）Seeds for the Treatment of Malignant Central Airway Stenosis</brief_title>
  <official_title>The Efficacy and Safety of a Metal Bare Stent With 125I Seeds for the Treatment of Malignant Central Airway Compared to a Metal Bare Stent: A Multicentric Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Xiamen Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Anhui Chest Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Meitan General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Fujian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Central Hospital of Wuhan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan No.1 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hunan People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yichang Central People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Affiliated Hospital of Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malignant central airway stenosis caused by primary or metastatic malignant tumor may lead to
      dyspnea even death of patients.With the rapid development of interventional pulmonology,
      bronchoscopic therapy has become the main treatment for malignant central airway stenosis.
      Metal stent implantation in airway can quickly relieve respiratory obstruction and improve
      quality of life.However, the tumor tissue can continue to grow into metal stent and obstruct
      airway again. This is the shortcoming of metal bare stents, which often need further
      treatment to keep airway open, including ablation, laser, cryotherapy, external radiotherapy
      or systemic anti-tumor drug therapy.Metal stent implantation combined with external
      radiotherapy can effectively reduce the incidence of airway restenosis.However, complications
      of external radiotherapy are high, including bone marrow suppression, radioactive pneumonia,
      radioactive esophagitis, myocardial injury and tracheoesophageal fistula, of which may cause
      serious consequences and even cause death of the patient.125I radioactive seeds have been one
      of the mature radioactive interventional therapy, which release X rays, and γ rays. Because
      of the short radioactive distance, 125I seeds can destruct tumor cells in tumor site and
      promote apoptosis and necrosis of tumor cells around the obstruction of the airway, meanwhile
      cause little damage to the surrounding normal tissues. Some studies showed that 125I seed
      implantation of lung tumor lesions achieved good short-term results.Therefore, the
      investigators hypothesize that 125I seeds fixed on the metal bare stent can not only improve
      the patient's breathing difficulties, but also play a role in killing tumor cells. At
      present, there have been reports of related clinical cases and monocentric control studies of
      malignant central airway stenosis treated with the implantation of metal stent with 125I
      seeds, but there is a lack of multicentric clinical studies with large samples.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is an open, multicentric randomized controlled clinical trial conducted in China, and plan
      to recruiting 200 patients who suffer malignant central airway stenosis. To evaluate the
      efficacy and safety of metal stent with 125I seeds group and metal bare stent group in the
      treatment of malignant central airway stenosis, follow-up should be done within 1 week, 1
      month, and 3 months after the first treatment, followed by every 3 months. The contents
      include review of bronchoscopy and chest CT, blood routine, immune indicators (IgA,
      immunoglobulin M（Ig M）, IgG), evaluation of general conditions. The patients of the first
      group need emission-computed tomography（ECT） imaging or positron emission tomography-computed
      tomography （PET-CT） examination within 1 month. If the patient has severe dyspnea, emergency
      bronchoscopy should be performed .
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2019</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>stenosis grade</measure>
    <time_frame>the first month after stent implantation</time_frame>
    <description>Stenosis grade was classified as 5 grades on the cross-sectional CT imaging area: grade 0
= non-appreciable stenosis; grade 1, 2, 3, and 4 = 25, 50, 75, and 90% decrease in area, respectively; grade 5 = complete obstruction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>stenosis grade</measure>
    <time_frame>the third month after stent implantation</time_frame>
    <description>Stenosis grade was classified as 5 grades on the cross-sectional CT imaging area: grade 0
= non-appreciable stenosis; grade 1, 2, 3, and 4 = 25, 50, 75, and 90% decrease in area, respectively; grade 5 = complete obstruction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival （OS）</measure>
    <time_frame>From randomization until death （up to 24 months）</time_frame>
    <description>overall survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>technical success</measure>
    <time_frame>one week after stent implantation</time_frame>
    <description>successful implantation of the stent across the stricture with appropriate positioning of the stent and full expansion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications and side effects</measure>
    <time_frame>From randomization until death （up to 24 months）</time_frame>
    <description>Possible radiation related complications included neutropenia, decrease in IgA, IgG, and IgM, and leakage of radioactive seeds.Neutropenia was defined as a total white blood cell count b4000/mm3 in the plasma. The leakage of radioactive seeds was defined as the detection of non-target radioactive source verified by radiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tumor growth rate</measure>
    <time_frame>From randomization until death （up to 24 months）</time_frame>
    <description>the size of tumor assessed by CT after stent implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the time of emergency endoscopic treatment</measure>
    <time_frame>From randomization until death （up to 24 months）</time_frame>
    <description>record the time of emergency endoscopic treatment for the recurrent severe dyspnea of patient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Malignant Airway Obstruction</condition>
  <arm_group>
    <arm_group_label>A metal bare stent with 125I seeds</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>125I seeds fixed on the metal bare stent, then stent implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A metal bare stent</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A metal bare stent implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>stent implantation</intervention_name>
    <description>stent implantation</description>
    <arm_group_label>A metal bare stent</arm_group_label>
    <arm_group_label>A metal bare stent with 125I seeds</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age range: 18-75 years old, male or female who is not pregnant

          2. Comply with the diagnosis of malignant central airway stenosis, and undergo chest CT
             or bronchoscopy to confirm that the stenosis degree is above 50% and need to be
             implanted with airway metal stent; or the patient has obvious dyspnea due to airway
             stenosis, obstructive pneumonia

          3. Subjects voluntarily joined the study and signed informed consent, with good
             compliance and follow-up.

          4. Unable or refused surgery

          5. Unable or refused external radiation therapy

          6. Unable or refuse systemic tumor-related drugs therapy within 3 months

        Exclusion Criteria:

          1. The distal end of the stenosis is unpredictable, and the stent treatment may not be
             satisfactory;

          2. Severe arrhythmia, acute myocardial ischemia, uncontrollable hypertensive crisis;

          3. Severe coagulopathy

          4. Severe organ dysfunction (except respiratory insufficiency)

          5. Allergic to anesthetics

          6. Airway fistula lesions

          7. The narrow lesion involves 2cm inside the glottis

          8. History of extrathoracic radiation therapy in the past 6 months

          9. Severe myelosuppression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chengshui Chen, doctor</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chengshui Chen, doctor</last_name>
    <phone>86 13806889081</phone>
    <phone_ext>8613806889081</phone_ext>
    <email>wzchencs@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaoxiao Lin, doctor</last_name>
    <phone>8615068252060</phone>
    <phone_ext>8615068252060</phone_ext>
    <email>295357950@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The first affiliated hospital of wenzhou medical university</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Ernst A, Feller-Kopman D, Becker HD, Mehta AC. Central airway obstruction. Am J Respir Crit Care Med. 2004 Jun 15;169(12):1278-97. Review.</citation>
    <PMID>15187010</PMID>
  </results_reference>
  <results_reference>
    <citation>Ong P, Grosu HB, Debiane L, Casal RF, Eapen GA, Jimenez CA, Noor L, Ost DE. Long-term quality-adjusted survival following therapeutic bronchoscopy for malignant central airway obstruction. Thorax. 2019 Feb;74(2):141-156. doi: 10.1136/thoraxjnl-2018-211521. Epub 2018 Sep 25.</citation>
    <PMID>30254139</PMID>
  </results_reference>
  <results_reference>
    <citation>Wood DE, Liu YH, Vallières E, Karmy-Jones R, Mulligan MS. Airway stenting for malignant and benign tracheobronchial stenosis. Ann Thorac Surg. 2003 Jul;76(1):167-72; discussion 173-4.</citation>
    <PMID>12842534</PMID>
  </results_reference>
  <results_reference>
    <citation>Saad CP, Murthy S, Krizmanich G, Mehta AC. Self-expandable metallic airway stents and flexible bronchoscopy: long-term outcomes analysis. Chest. 2003 Nov;124(5):1993-9.</citation>
    <PMID>14605078</PMID>
  </results_reference>
  <results_reference>
    <citation>Sabath BF, Ost DE. Update on airway stents. Curr Opin Pulm Med. 2018 Jul;24(4):343-349. doi: 10.1097/MCP.0000000000000486. Review.</citation>
    <PMID>29538079</PMID>
  </results_reference>
  <results_reference>
    <citation>Lemaire A, Burfeind WR, Toloza E, Balderson S, Petersen RP, Harpole DH Jr, D'Amico TA. Outcomes of tracheobronchial stents in patients with malignant airway disease. Ann Thorac Surg. 2005 Aug;80(2):434-7; discussion 437-8.</citation>
    <PMID>16039180</PMID>
  </results_reference>
  <results_reference>
    <citation>Rochet N, Hauswald H, Schmaus M, Hensley F, Huber P, Eberhardt R, Herth FJ, Debus J, Neuhof D. Safety and efficacy of thoracic external beam radiotherapy after airway stenting in malignant airway obstruction. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e129-35. doi: 10.1016/j.ijrobp.2011.11.055.</citation>
    <PMID>22516383</PMID>
  </results_reference>
  <results_reference>
    <citation>Qu A, Wang H, Li J, Wang J, Liu J, Hou Y, Huang L, Zhao Y. Biological effects of (125)i seeds radiation on A549 lung cancer cells: G2/M arrest and enhanced cell death. Cancer Invest. 2014 Jul;32(6):209-17. doi: 10.3109/07357907.2014.905585. Epub 2014 Apr 18.</citation>
    <PMID>24745612</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Y, Lu J, Guo JH, Zhu GY, Zhu HD, Chen L, Wang C, Teng GJ. A Novel Tracheobronchial Stent Loaded with (125)I Seeds in Patients with Malignant Airway Obstruction Compared to a Conventional Stent: A Prospective Randomized Controlled Study. EBioMedicine. 2018 Jul;33:269-275. doi: 10.1016/j.ebiom.2018.06.006. Epub 2018 Jun 14.</citation>
    <PMID>29909977</PMID>
  </results_reference>
  <results_reference>
    <citation>Lu M, Pu D, Zhang W, Liao J, Zhang T, Yang G, Liu Z, Singh S, Gao F, Zhang F. Trans-bronchoscopy with implantation of (125)I radioactive seeds in patients with pulmonary atelectasis induced by lung cancer. Oncol Lett. 2015 Jul;10(1):216-222. Epub 2015 May 13.</citation>
    <PMID>26171002</PMID>
  </results_reference>
  <results_reference>
    <citation>Mallick I, Sharma SC, Behera D. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life. Lung Cancer. 2007 Mar;55(3):313-8. Epub 2006 Dec 8.</citation>
    <PMID>17157949</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang Y, Guo JH, Zhu GY, Zhu HD, Chen L, Lu J, Wang C, Teng GJ. A Novel Self-Expandable, Radioactive Airway Stent Loaded with (125)I Seeds: A Feasibility and Safety Study in Healthy Beagle Dog. Cardiovasc Intervent Radiol. 2017 Jul;40(7):1086-1093. doi: 10.1007/s00270-017-1639-8. Epub 2017 Apr 7.</citation>
    <PMID>28389860</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 5, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>May 8, 2019</last_update_submitted>
  <last_update_submitted_qc>May 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Airway Obstruction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

